Press Releases - Exact Sciences
Nov 5, 2024 · Exact Sciences is working to eradicate cancer by delivering a portfolio that gives providers the information they need to better serve their patients across the cancer care continuum — starting with familial risk. Read more
News and events - Exact Sciences
Nov 5, 2024 · Exact Sciences is working to eradicate cancer by delivering a portfolio that gives providers the information they need to better serve their patients across the cancer care continuum — starting with familial risk.
Cancer Prevention, Screening & Therapy Guidance | Exact Sciences
Explore Exact Sciences, a leading provider of tests for cancer prevention, early detection and screening, and therapy guidance.
Exact Sciences Announces Third-Quarter 2024 Results
Nov 5, 2024 · Exact Sciences is working to eradicate cancer by delivering a portfolio that gives providers the information they need to better serve their patients across the cancer care continuum — starting with familial risk. Read more
News and events - Exact Sciences
Stay up to date with Exact Sciences’ news, announcements, patient stories, and events.
Cologuard® test | Exact Sciences
News and events. Explore stories, news, and events that highlight our innovation, technology, and people fighting cancer on all fronts. View news and events
FDA Approves Exact Sciences’ Cologuard Plus Test
Oct 4, 2024 · Building on the success of the Cologuard® and Oncotype® tests, Exact Sciences is investing in its pipeline to develop innovative solutions for use before, during, and after a cancer diagnosis.
Exact Sciences Advances Innovative Cancer Technologies and …
Jun 21, 2023 · Exact Sciences is working to eradicate cancer by delivering a portfolio that gives providers the information they need to better serve their patients across the cancer care continuum — starting with familial risk.
Court Ruling Enables Exact Sciences to Proceed with Lawsuit …
On May 15, 2024, Exact Sciences filed a second complaint against Geneoscopy to defend its intellectual property against infringement in the United States District Court for the District of Delaware. The case asserts a new patent, the ’746 patent, …
New England Journal of Medicine Publishes Cologuard ... - Exact …
Mar 13, 2024 · Exact Sciences submitted to the U.S. Food and Drug Administration (FDA) its pre-market approval (PMA) application for Cologuard Plus in December 2023, including complete results from BLUE-C, and plans to make the test available in 2025, pending approval.